Join Now

Author Archives: Natalie Themm

BlueWind Medical enrolls 100th patient in OASIS study of Renova iStim system

By Natalie Themm | Published September 9, 2021

BlueWind Medical has announced that the 100th patient has been enrolled in its OASIS (Overactive bladder stimulation system) study—a clinical pivotal trial designed to test the safety and efficacy of the Renova iStim system in providing tibial neuromodulation (TNM) therapy.

Posted in BioUtah News | Tagged | Leave a comment

Co-Diagnostics, Inc. SARS-CoV-2 Test Used in New Community Surveillance Method in Italy

By Natalie Themm | Published September 8, 2021

Peer-reviewed results describe the Company’s test being used to confirm the presence of the virus on community waste, including mutated strains

Posted in BioUtah News | Tagged | Leave a comment

U.S. Rep. Burgess Owens Spends a Day in the BioHive

By Natalie Themm | Published September 2, 2021

On Monday, U.S. Rep. Burgess Owens (R-UT-4) spent the day visiting a number of life sciences companies – Owlet, Spectrum Solutions, Merit Medical, Matia Robotics and ARUP Laboratories.

Posted in BioUtah News | Tagged | Leave a comment

Mountain Pacific Announces New Funding Opportunities

By Natalie Themm | Published September 2, 2021

Ron Heffernan, Managing Partner at Mountain Pacific Partners recently announced the launch of Mountain Pacific’s newest funds.

Posted in BioUtah News | Tagged , | Leave a comment

PhotoPharmics Appoints Dr. Karl Kieburtz as Chief Medical Officer

By Natalie Themm | Published August 31, 2021

World-renowned neurologist and movement disorders specialist joins PhotoPharmics as company advances breakthrough device through pivotal clinical trial and to commercialization.

Posted in BioUtah News | Tagged | Leave a comment

Renalytix Appoints Daniel J. Levangie to its Board of Directors

By Natalie Themm | Published August 31, 2021

Levangie brings extensive commercial operating experience to Renalytix, served on boards of Exact Sciences, Insulet Corporation and Hologic.

Posted in BioUtah News | Tagged | Leave a comment

Mountain Pacific Partners Invests $2M in Growth Capital into Alterra Medical

By Natalie Themm | Published August 31, 2021

Salt Lake City-based specialty medical device distributor is poised for value-creating diversification and supply chain innovation.

Posted in BioUtah News | Tagged , | Leave a comment

Alterra Medical Announces Jeff Hastings as New Chief Executive Officer

By Natalie Themm | Published August 31, 2021

With more than two decades of healthcare expertise, Hastings brings track record of leading transformative growth.

Posted in BioUtah News | Tagged | Leave a comment

ARUP’s Investment Will Help Boost Development of Techcyte’s AI-Enabled Diagnostics Platform

By Natalie Themm | Published August 31, 2021

ARUP Laboratories recently announced an investment in Techcyte Inc. as part of the Orem, Utah-based company’s new $21 million funding round.

Posted in BioUtah News | Tagged , | Leave a comment

ANNUAL BIOUTAH AWARDS

By Natalie Themm | Published August 26, 2021

Nominations are now open for BioUtah’s 2021 awards. The deadline for nominations is September 18.

Posted in BioUtah News | Tagged | Leave a comment

KNOWN MEDICINE RAISES $7.2 MILLION SEED ROUND TO ADVANCE DATA FIRST APPROACH TO ORGANOID TECHNOLOGY

By Natalie Themm | Published August 26, 2021

Known Medicine today announced the closure of its seed round of funding in the amount of $7.2 million led by Caffeinated Capital, with participation from Khosla Ventures, Cota Capital, Kickstart, Forward VC, OATV, Y Combinator and noted angel investors Chris Gibson, CEO & Co-Founder at Recursion Pharmaceuticals, Nish Bhat, previously Co-Founder at Color Genomics, and others.

Posted in BioUtah News | Tagged | Leave a comment

Fluidx Medical Technology’s Innovative Embolic Tumor Treating Device Highlighted in “BEST of GEST” Session at the Global Embolization Oncology Symposium Technologies (“GEST”) Conference

By Natalie Themm | Published August 26, 2021

Fluidx Medical’s GPX™ Embolic Device Use for Tumor Treatments Chosen for “BEST of GEST” Embolization Program at the Annual GEST Meeting.

Posted in BioUtah News | Tagged , | Leave a comment

A Special Thanks To Our Legacy and Platinum Elite Members